2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

Chern En Chiang, Tsu Juey Wu, Kwo Chang Ueng, Tze Fan Chao, Kuan Cheng Chang, Chun Chieh Wang, Yenn Jiang Lin, Wei Hsian Yin, Jen Yuan Kuo, Wei Shiang Lin, Chia Ti Tsai, Yen Bin Liu, Kun Tai Lee, Li Jen Lin, Lian Yu Lin, Kang Ling Wang, Yi-Jen Chen, Mien Cheng Chen, Chen Chuan Cheng, Ming Shien WenWen Jone Chen, Jyh Hong Chen, Wen Ter Lai, Chuen Wang Chiou, Jiunn Lee Lin, San Jou Yeh, Shih Ann Chen

研究成果: 雜誌貢獻文章

54 引文 斯高帕斯(Scopus)

摘要

Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.
原文英語
頁(從 - 到)893-952
頁數60
期刊Journal of the Formosan Medical Association
115
發行號11
DOIs
出版狀態已發佈 - 十一月 1 2016

Keywords

  • ablation
  • antiarrhythmic agents
  • anticoagulation
  • atrial fibrillation
  • non-vitamin K antagonist oral anticoagulant
  • vitamin K antagonist

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation」主題。共同形成了獨特的指紋。

  • 引用此

    Chiang, C. E., Wu, T. J., Ueng, K. C., Chao, T. F., Chang, K. C., Wang, C. C., Lin, Y. J., Yin, W. H., Kuo, J. Y., Lin, W. S., Tsai, C. T., Liu, Y. B., Lee, K. T., Lin, L. J., Lin, L. Y., Wang, K. L., Chen, Y-J., Chen, M. C., Cheng, C. C., ... Chen, S. A. (2016). 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. Journal of the Formosan Medical Association, 115(11), 893-952. https://doi.org/10.1016/j.jfma.2016.10.005